The VHL tumour-suppressor gene paradigm
- 1 October 1998
- journal article
- review article
- Published by Elsevier in Trends in Genetics
- Vol. 14 (10) , 423-426
- https://doi.org/10.1016/s0168-9525(98)01558-3
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Human Cancer Syndromes: Clues to the Origin and Nature of CancerScience, 1997
- von Hippel-Lindau DiseaseMedicine, 1997
- Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissuesHuman Pathology, 1997
- Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesisHuman Molecular Genetics, 1996
- Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and JapanHuman Mutation, 1996
- Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effectHuman Genetics, 1995
- Identification of intragenic mutations in the Von Hippel — Lindau disease tumour suppressor gene andcorrelation with disease phenotypeHuman Molecular Genetics, 1994
- Identification of the von Hippel-Lindau Disease Tumor Suppressor GeneScience, 1993
- Clinical Features and Natural History of von Hippel-Lindau DiseaseQJM: An International Journal of Medicine, 1990
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971